Related references
Note: Only part of the references are listed.Prevention of Acute Kidney Injury by Tauroursodeoxycholic Acid in Rat and Cell Culture Models
Sandeep Gupta et al.
PLOS ONE (2012)
Prodrugs-from Serendipity to Rational Design
Kristiina M. Huttunen et al.
PHARMACOLOGICAL REVIEWS (2011)
Bile acids: regulation of apoptosis by ursodeoxycholic acid
Joana D. Amaral et al.
JOURNAL OF LIPID RESEARCH (2009)
Water-Soluble Prodrugs of the Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir
David A. DeGoey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats
Ahmet Colak et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Your prodrug releases formaldehyde: Should you be concerned? No!
Sundeep S. Dhareshwar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C
Masao Omata et al.
GUT (2007)
Prodrug strategies to overcome poor water solubility
Valentino J. Stella et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Davide Festi et al.
CURRENT CLINICAL PHARMACOLOGY (2007)
Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat
Andrew L. Rivard et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2007)
Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver
M Arat et al.
CLINICAL TRANSPLANTATION (2005)
Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-β1-induced apoptosis in rat hepatocytes
S Solá et al.
HEPATOLOGY (2005)
Differentially-protected steroidal triamines; scaffolds with potential for medicinal, supramolecular, and combinatorial chemistry
V del Amo et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2004)
Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues
L Bialy et al.
CHEMISTRY-A EUROPEAN JOURNAL (2004)
Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor β1-induced apoptosis of rat hepatocytes
S Solá et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats
CMP Rodrigues et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome c release in isolated mitochondria
CMP Rodrigues et al.
BIOCHEMISTRY (2003)
Synthesis of 2-deoxy-beta-D-ribose 1-phosphate, NMR comparison and its enzymatic activity for structural elucidation of synthetic alpha-isomer
H Komatsu et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2003)
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
G Paumgartner et al.
HEPATOLOGY (2002)
First stereoselective synthesis of 2-deoxy-α-D-ribosyl-1-phosphate:: Novel application of crystallization-induced asymmetric transformation
H Komatsu et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
A novel synthetic route for the preparation of alkyl and benzyl chloromethyl phosphates
A Mäntyla et al.
TETRAHEDRON LETTERS (2002)
Neuroprotection by a bile acid in an acute stroke model in the rat
TMP Rodrigues et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease
CD Keene et al.
EXPERIMENTAL NEUROLOGY (2001)
Share Paper
